Sale of Spinal Implants Business |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Discontinued Operations and Disposal Groups [Abstract] | |
| Sale of Spinal Implants Business | SALE OF SPINAL IMPLANTS BUSINESS In April 2025 we completed the sale of the disposal group to the Viscogliosi Brothers, LLC. The fair value of the consideration received of $245 was measured using a discounted cash flow analysis based upon the selling price and unobservable inputs, such as market conditions and the rate used to discount the estimated future cash flows to their present value based on factors including the disposal group’s cost of equity and market yield rates, which are Level 3 inputs. Deferred consideration receivable was $269 at March 31, 2026. Other amounts due from Viscogliosi Brothers, LLC are not material. Amounts due from purchasers in connection with divestitures, including deferred consideration, are assessed periodically for collectability. This assessment involves significant judgment and considers, among other factors, the purchaser’s financial condition, operating performance and ability to meet its contractual obligations. The carrying value of such amounts may be adjusted if, based on the facts and circumstances available, collection is no longer considered probable.
|